Phenotypic and genetic alterations in mammary stroma: Implications for tumour progression

Breast Cancer Research

Volumn 3, Issue 6, 2001, Pages 373-379

  Schor, Seth L ^a   Schor, Ana M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer progression; Cell motility; Epithelial stromal interactions; Fibronectin

Indexed keywords

CYTOKINE; FIBRONECTIN; ISOPROTEIN; MATRIX PROTEIN; MIGRATION STIMULATING FACTOR; PEPTIDE FRAGMENT; PROTEINASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CELL INTERACTION; CONTROLLED STUDY; DISEASE COURSE; FETUS; FETUS CELL; FIBROBLAST; GENETIC MANIPULATION; HUMAN; HUMAN CELL; MACROMOLECULE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR CELL;

BREAST; BREAST NEOPLASMS; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; FIBROBLASTS; HUMANS; PHENOTYPE; STROMAL CELLS;

EID: 0035720007     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: 10.1186/bcr325     Document Type: Article

References (47)

1. Multistep carcinogenesis of breast cancer and tumour heterogeneity
2. Genetic pathways in colorectal and other cancers
3. Expression genetics in cancer: Shifting the focus from DNA to RNA
4. Hypothesis: Persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease
5. Stromal acceleration of tumour progression: Role of 'fetal-like' fibroblast subpopulations
6. The role of the stroma in breast carcinoma growth in vivo
7. Epithelial-mesenchymal interactions in the development and maintenance of epithelial tissues
8. Expression of growth factors, growth inhibitory factors and their receptors in invasive breast cancer: An inventory in search of autocrine and paracrine loops
9. Paracrine/autocrine regulation of breast cancer by insulin-like growth factors
10. Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation
11. Cytokine control of cell motility: Modulation and mediation by the extracellular matrix
12. Extracellular matrix remodelling and cellular differentiation
13. Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands
14. The interdependent modulation of hyaluronan synthesis by TGF-β1 and extracellular matrix: Consequences for the control of cell migration
15. Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix
16. Motogenic and biosynthetic response of adult skin fibroblasts to TGF isoforms (-1, -2, and -3) determined by 'tissue response unit': Role of cell density and substratum
17. Effects of culture conditions on the proliferation and morphology of bovine aortic endothelial cells in vitro: Reversible expression of the sprouting cell phenotype
18. Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum
19. Tensegrity: The architectural basis of cellular mechanotransduction
20. A novel metallo-proteinase gene specifically expressed in stromal cells of breast carcinomas
21. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas
22. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
23. Matrix metalloproteinases: Multi-functional contributors to tumor progression
24. Regulation of tissue injury responses by exposure of matricryptic sites within extracellular matrix molecules
25. Proteases in invasion: Matrix metalloproteinases
26. Release of biological activities from quiescent fibronectin by a conformational change and limited proteolysis by matrix metalloproteinases
27. Integrin adhesion receptors: Structure, function and implications for biomedicine
28. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin
29. Motogenic activity of the IGD amino acid motif
30. Adult, fetal and transformed fibroblasts display different migratory phenotypes on collagen gels: Evidence for an isoformic transition during fetal development
31. Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro
32. Occurrence of a foetal fibroblast phenotype in familial breast cancer
33. Fibroblasts from relatives of hereditary breast cancer patients display fetal-like behaviour in vitro
34. Foetal and cancer patient fibroblasts produce an autocrine migration stimulating factor not made by normal adult cells
35. Migration stimulating activity in the serum of breast cancer patients
36. Purification of the migration stimulating factor produced by fetal and cancer patient fibroblasts
37. Migration stimulating factor: Its structural homology to the gelatin-binding domain of fibronectin, mode of action and possible function in health and disease
38. Mechanism of action of the migration stimulating factor (MSF) produced by fetal and cancer patient fibroblasts: Effect on hyaluronic acid synthesis
39. Phenotypic heterogeneity in breast fibroblasts: Functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma
40. Source of oncofetal ED-B fibronectin: Implications of production by both tumor and endothelial cells
41. The fibronectin isoform containing the ED-B oncofetal domain: A marker of angiogenesis
42. Vascular stroma formation in carcinoma in situ, invasive carcinoma and metastatic carcinoma of the breast
43. Antagonistic effects of transforming growth factor beta and MSF on fibroblast migration and hyaluronic acid synthesis: Possible implications for wound healing
44. Quantitative variation in protooncogene and cytokine gene expression in isolated breast fibroblasts
45. Discrimination of fibroblast subtypes by multivariate analysis of gene expression
46. Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal and endodermal origin: Indicator of a fetal cell phenotype
47. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: Implications for tumorigenesis